Publications by authors named "Afreen Shariff"

Claim this Profile
H
High-Risk Prostate Cancer in a Patient with Untreated Prolactinoma and Castrate-Level Testosterone Suppression: A Case Report.
Tara A Seibert, Afreen Shariff, Hannah D McManus

Case Rep Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.
Ling Zhu, Yee-Ming M Cheung, Cherie Chiang, Emily J Gallagher, Ole-Petter R Hamnvik, Afreen Shariff

J Immunother Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.
Eileen L Chang, Renee Liu, Kiandokht Keyhanian, Katie Huynh, Meghan Berkenstock, Afreen Shariff

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired Generalized Lipodystrophy as an Adverse Event of Combined Immune Checkpoint Inhibitor Therapy.
Randol Kennedy, Calvin Rei L Macrohon, Mary Lourdes Grace V David, Meg Lee, April K S Salama, Afreen Shariff

JCEM Case Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrinopathies Associated With Immune Checkpoint Inhibitor Use.
Anupam Kotwal, Randol Kennedy, Nupur Kikani, Sonali Thosani, Whitney Goldner, Afreen Shariff

Endocr Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner, Afreen Shariff

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating ethical and quality principles for the effective, safe and fair development, deployment and use of artificial intelligence technologies in healthcare.
Nicoleta J Economou-Zavlanos, Sophia Bessias, Michael P Cary, Armando D Bedoya, Benjamin A Goldstein, Afreen Idris Shariff

J Am Med Inform Assoc· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy.
Howa Yeung, Krittin J Supapannachart, Sandy Francois, Colin H Adler, Ragini R Kudchadkar, Afreen I Shariff

JID Innov· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of toxicities from immune, targeted and ADCs treatments in patients with urothelial cancer.
Saad Atiq, Nathan Hirshman, Afreen Shariff, Tian Zhang

Urol Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation of bilateral adrenal metastases is associated with a high risk of primary adrenal insufficiency.
Justine Herndon, Christopher Hallemeier, Krishan Jethwa, Afreen Shariff, Irina Bancos

Clin Endocrinol (Oxf)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dearth of ICD Codes for Complications of Immune Checkpoint Inhibitors Impedes Clinical Care and Research.
Yee-Ming M Cheung, Ole-Petter R Hamnvik, Afreen Shariff, Emily J Gallagher

J Endocr Soc· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top Ten Tips Palliative Care Clinicians Should Know About Managing Immune-Mediated Endocrine Toxicities in Cancer.
Michelle N Ferreira, Meghana Rao, Arif H Kamal, Afreen Shariff

J Palliat Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial.
Jeffrey M Clarke, Lin Gu, Xiaofei F Wang, Thomas E Stinchcombe, Marvaretta M Stevenson, Afreen Shariff

JTO Clin Res Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's the Price? Toxicities of Targeted Therapies in Breast Cancer Care.
Carey K Anders, Nicole R LeBoeuf, Lara Bashoura, Saadia A Faiz, Afreen I Shariff

Am Soc Clin Oncol Educ Book· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Carbohydrate and Very-Low-Carbohydrate Diets in Patients With Diabetes.
Jennifer D Merrill, Diana Soliman, Nitya Kumar, Sooyoung Lim, Afreen I Shariff

Diabetes Spectr· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 Diabetes and Atherosclerotic Cardiovascular Disease in South Asians: a Unique Population with a Growing Challenge.
Afreen I Shariff, Nitya Kumar, William S Yancy, Leonor Corsino

Curr Diab Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel cancer therapies and their association with diabetes.
Afreen Idris Shariff, Sohail Syed, Rebecca A Shelby, Jeremy Force, Jeffrey Melson Clarke

J Mol Endocrinol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A RARE CASE OF PRIMARY HYPERPARATHYROIDISM, HYPEREMESIS GRAVIDARUM, AND WERNICKE ENCEPHALOPATHY.
Jennifer Stahl, Niki Winters, Afreen Shariff

AACE Clin Case Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions.
Rebecca Herbst, Wilburn Bolton, Afreen Shariff, Jennifer B Green

Curr Diab Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions.
Negin Misaghian-Xanthos, Afreen I Shariff, Kavya Mekala, Loretta R Fearrington, Tracy L Setji

Diabetes Care· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the Twitter Influence of Third Party Commercial Entities versus Healthcare Providers in Thirteen Medical Conferences from 2011 - 2013.
Tejas Desai, Vibhu Dhingra, Afreen Shariff, Aabid Shariff, Edgar Lerma

PLoS One· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is content really king? An objective analysis of the public's response to medical videos on YouTube.
Tejas Desai, Afreen Shariff, Vibhu Dhingra, Deeba Minhas, Megan Eure

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using social media to create a professional network between physician-trainees and the American Society of Nephrology.
Afreen I Shariff, Xiangming Fang, Tejas Desai

Adv Chronic Kidney Dis· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tweeting the meeting: an in-depth analysis of Twitter activity at Kidney Week 2011.
Tejas Desai, Afreen Shariff, Aabid Shariff, Mark Kats, Xiangming Fang

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis